加速度计
骨关节炎
体力活动
联想(心理学)
医学
物理医学与康复
物理疗法
心理学
计算机科学
替代医学
病理
操作系统
心理治疗师
作者
Tianxiang Fan,Qiyu Xie,Jiawei Chen,Muhui Zeng,Shibo Chen,Hao Yang,Guangfeng Ruan,Qian Yang,Yujie Zhang,Ye Li,Peihua Cao,Kim L. Bennell,Amy SN Fu,David J. Hunter,Changhai Ding,Zhaohua Zhu
出处
期刊:Rheumatology
[Oxford University Press]
日期:2026-04-11
卷期号:65 (5)
标识
DOI:10.1093/rheumatology/keag179
摘要
OBJECTIVE: To explore the associations between accelerometer-measured physical activity patterns and cardiovascular diseases (CVD), CVD-cause mortality and all-cause mortality in people with osteoarthritis (OA). METHODS: OA participants from the UK biobank with ≥36 h of accelerometer data, collected over one-week, were analysed. Moderate to vigorous physical activity (MVPA) patterns were classified as: 'weekend warriors' (≥150 min/week, >50% on 1-2 days), active regular (>150 min/week) or inactive (<150 min/week). Mean min per week of light physical activity (LPA) were categorized into quartiles based on the distribution in the analytical sample. RESULTS: Among 10 210 study participants (mean age 58.1 ± 7.1 years; 64.5% female) followed for a median of 6.9 years, there were 1538 incident cases of CVD, and 358 deaths, including 90 from CVD. Compared with inactive MVPA, both weekend warrior [adjusted hazard ratio, aHR (95% CIs); 0.73 (0.64-0.82)] and active regular MVPA [0.75 (0.65-0.87)] significantly lowered the risks of incident CVD. Notably, only the weekend warrior group showed significant reductions in CVD-cause mortality (0.55, 0.33-0.92), and all-cause mortality [0.75 (0.59-0.96)]. Higher levels of LPA may link to lower CVD, CVD-cause mortality and all-cause mortality risks in a dose-response manner. Subgroup analysis indicated that more prominent associations were found in individuals with a body mass index >30 or those aged over 60. CONCLUSION: Engaging in a weekend warrior pattern may confer unique survival benefits for OA patients, especially among older adults and those with obesity. LPA may have dose-dependent protective effects for CVD and mortality risk in OA patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI